There is limited treatment options for the most common form of monogenic obesity, MC4R mutations symptoms can be treated with a Glucagon-like Peptide-1 Receptor Agonist liraglutide which cause weight loss by reducing appetite
The pill is 25 milligrams of semaglutide, the same active ingredient in injectable Wegovy and Ozempic, and will be sold under the brand name Wegovy
While they are naturally produced within the body, synthetic peptides have gained attention for their potential health benefits
89 In addition, having depression has been associated with greater risk of cancer
Khalili, A., Alipour, S., Fathalipour, M., Purkhosrow, A., Mashghoolozekr, E., Bayat, G., & Nekooeian, A